Pharmacological and Physiological Functions of the Polyspecific Organic Cation Transporters: OCT1, 2, and 3 (SLC22A1-3)

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2004-01-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/JPET.103.053298PMID 14576340
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The SLC22 drug transporter family

  2004influential reference
• Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations

  2003cited by this paper
• Agmatine Is Efficiently Transported by Non-Neuronal Monoamine Transporters Extraneuronal Monoamine Transporter (EMT) and Organic Cation Transporter 2 (OCT2)

  2003cited by this paper
• The superfamily of organic anion transporting polypeptides.

  2003cited by this paper
• Organic cation transporters.

  2003cited by this paper
• Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)

  2003cited by this paper
• Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1

  2003cited by this paper
• Natural variation in human membrane transporter genes reveals evolutionary and functional constraints

  2003cited by this paper
• Involvement of organic cation transporter 1 in the lactic acidosis caused by metformin.

  2003cited by this paper
• Molecular cloning of rabbit organic cation transporter rbOCT2 and functional comparisons with rbOCT1.

  2002cited by this paper
• Involvement of Organic Cation Transporter 1 in Hepatic and Intestinal Distribution of Metformin

  2002influential reference
• Molecular identification of a renal urate–anion exchanger that regulates blood urate levels

  2002cited by this paper
• Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.

  2002influential reference
• Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins.

  2002cited by this paper
• cDNA cloning, functional characterization, and tissue distribution of an alternatively spliced variant of organic cation transporter hOCT2 predominantly expressed in the human kidney.

  2002cited by this paper
• Catalog of 238 variations among six human genes encoding solute carriers (hSLCs) in the Japanese population

  2002cited by this paper
• The Cation Transporters rOCT1 and rOCT2 Interact with Bicarbonate but Play Only a Minor Role for Amantadine Uptake into Rat Renal Proximal Tubules

  2002cited by this paper
• Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes

  2002cited by this paper
• Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences.

  2002influential reference
• Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels.

  2002influential reference
• The organic anion transporter family: from physiology to ontogeny and the clinic.

  2001influential reference
• Impaired Activity of the Extraneuronal Monoamine Transporter System Known as Uptake-2 inOrct3/Slc22a3-Deficient Mice

  2001influential reference
• Reduced Hepatic Uptake and Intestinal Excretion of Organic Cations in Mice with a Targeted Disruption of the Organic Cation Transporter 1 (Oct1 [Slc22a1]) Gene

  2001cited by this paper
• Comparison of "type I" and "type II" organic cation transport by organic cation transporters and organic anion-transporting polypeptides.

  2001cited by this paper
• Bidirectional action of the Igf2r imprint control element on upstream and downstream imprinted genes.

  2001cited by this paper
• Ventricular Choline Transport

  2001cited by this paper
• The role of neuronal and extraneuronal plasma membrane transporters in the inactivation of peripheral catecholamines.

  2001cited by this paper
• Gene structure prediction and alternative splicing analysis using genomically aligned ESTs.

  2001cited by this paper
• Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1)

  2000cited by this paper
• Synthesis and purification of horseradish peroxidase-labeled oligonucleotides for tyramide-based fluorescence in situ hybridization

  2000cited by this paper
• Differential localization of organic cation transporters rOCT1 and rOCT2 in the basolateral membrane of rat kidney proximal tubules

  2000cited by this paper
• Role of organic cation transporters in the renal secretion of nucleosides.

  2000influential reference
• Hormonal regulation of organic cation transporter OCT2 expression in rat kidney

  2000cited by this paper
• Localization of organic cation transporters OCT1 and OCT2 in rat kidney.

  2000influential reference
• Expression of the extraneuronal monoamine transporter in RPE and neural retina

  2000cited by this paper
• Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1/SLC22A1)

  1999cited by this paper
• Selective substrates for non-neuronal monoamine transporters.

  1999cited by this paper
• Cloning of the mouse organic cation transporter 2 gene, Slc22a2, from an enhancer-trap transgene integration locus

  1999cited by this paper
• Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27.

  1999influential reference
• Gender differences in expression of organic cation transporter OCT2 in rat kidney

  1999cited by this paper
• Identity of the Organic Cation Transporter OCT3 as the Extraneuronal Monoamine Transporter (uptake2) and Evidence for the Expression of the Transporter in the Brain*

  1998influential reference
• Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter

  1998influential reference
• Transport of Monoamine Transmitters by the Organic Cation Transporter Type 2, OCT2*

  1998influential reference
• Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.

  1998cited by this paper
• Cloning and Functional Characterization of a Potential-sensitive, Polyspecific Organic Cation Transporter (OCT3) Most Abundantly Expressed in Placenta*

  1998influential reference
• Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa).

  1998cited by this paper
• Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine.

  1998influential reference
• cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family.

  1998influential reference
• Catecholamine transport by the organic cation transporter type 1 (OCT1)

  1998influential reference
• Molecular cloning and functional expression of a rabbit renal organic cation transporter.

  1998cited by this paper
• Membrane localization of the electrogenic cation transporter rOCT1 in rat liver.

  1998cited by this paper
• Cloning and functional expression of a human liver organic cation transporter.

  1997influential reference
• The uptake of catechol amines at high perfusion concentrations in the rat isolated heart: a novel catechol amine uptake process

  1997cited by this paper
• Cloning and Characterization of Two Human Polyspecific Organic Cation Transporters

  1997influential reference
• Primary Structure and Functional Expression of the Apical Organic Cation Transporter from Kidney Epithelial LLC-PK1Cells*

  1997influential reference
• Cloning and Functional Characterization of a Rat Renal Organic Cation Transporter Isoform (rOCT1A)*

  1997influential reference
• The Lxl gene maps to mouse Chromosome 17 and codes for a protein that is homologous to glucose and polyspecific transmembrane transporters

  1996cited by this paper
• cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2.

  1996cited by this paper
• Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1

  1996cited by this paper
• Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1*

  1996cited by this paper
• Drug excretion mediated by a new prototype of polyspecific transporter

  1994cited by this paper
• A Textbook of Histology

  1936cited by this paper
• J Am Soc Nephrol 13: 866–874, 2002 Gene Expression Levels and Immunolocalization of Organic Ion Transporters in the Human Kidney

  year unknowncited by this paper

• COMPUTATIONAL DRUG DISCOVERY OF POTENT ANTIMALARIAL XANTHONES: A SYSTEMATIC REVIEW AND ADMET-GUIDED IDENTIFICATION OF A LEAD CANDIDATE

  2025cites this paper
• Ex vivo perfusion model of mouse liver and its application to analyze the effects of OCT1 deficiency

  2025cites this paper
• Methyl 2-(7-hydroxy-3-methyloctyl)-1,3-dimethyl-4-oxocyclohex-2-enecarboxylate as a natural and potent antitubercular lead: An in silico study integrating molecular docking, molecular dynamics, FMO, and DFT analyses

  2025cites this paper
• Transporters and drug secretion into human breast milk

  2025cites this paper
• Organic cation transporter-3 mediates exogenous histamine uptake by primary mast cells

  2025cites this paper
• Chronic liver injury decreases levels of cerebral carnitine and acetylcarnitine in rats partly due to the downregulation of organic cation transporters OCT1/2 and OCTN2 at the blood-brain barrier.

  2025cites this paper
• Diallyl Trisulfide, an Active Substance from Garlic, Inhibits Female Oviposition by Decreasing the Expression of the OCT Gene, which is Highly Expressed in the Spermathecal Gland of Sitotroga cerealella (Oliver).

  2025cites this paper
• Multigenetic pharmacogenomics–guided treatment shows greater improvements on motor symptoms compared to usual therapy in Parkinson’s disease: a small real-word prospective cohort study

  2025cites this paper
• Targeting Solute Carrier Transporters (SLCs) as a Therapeutic Target in Different Cancers

  2024cites this paper
• Pediatric flecainide pharmacogenomics: a roadmap to delivering precision-based care to pediatrics arrhythmias

  2024cites this paper
• Metformin inhibits OCTN1- and OCTN2-mediated hepatic accumulation of doxorubicin and alleviates its hepatotoxicity in mice.

  2024cites this paper
• An update on the pharmacogenetic considerations when prescribing dopamine receptor agonists for Parkinson’s disease

  2023cites this paper
• Clocking Epilepsies: A Chronomodulated Strategy-Based Therapy for Rhythmic Seizures

  2023cites this paper
• Metabolic basis of solute carrier transporters in treatment of type 2 diabetes mellitus

  2023cites this paper
• The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy

  2023cites this paper
• Exploration of CviR-mediated quorum sensing inhibitors from Cladosporium spp. against Chromobacterium violaceum through computational studies

  2023cites this paper
• Association between organic cation transporter genetic polymorphisms and metformin response and intolerance in T2DM individuals: a systematic review and meta-analysis

  2023cites this paper
• Modeling the Double Peak Phenomenon in Drug Absorption Kinetics: The Case of Amisulpride

  2023cites this paper
• A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer

  2023cites this paper
• Genetic variation in organic cation transporters and considerations in drug development

  2023cites this paper
• Strong inhibition of organic cation transporter 2 by flavonoids and attenuation effects on cisplatin-induced cytotoxicity.

  2023cites this paper
• Pharmacogenomics-Guided Multi-Gene Therapy Yields Superior Motor Symptom Improvement Over Standard Treatment in Parkinson’s Disease: Insights from a Small Real-World Prospective Cohort Study

  2022cites this paper
• The complicated lives of GPCRs in cardiac fibroblasts.

  2022cites this paper
• Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[211At]astato-benzylguanidine.

  2022cites this paper
• Insight into the interplay between mitochondria-regulated cell death and energetic metabolism in osteosarcoma

  2022cites this paper
• GPCRs in Intracellular Compartments: New Targets for Drug Discovery

  2022cites this paper
• Computational Characterizing Necroptosis Reveals Implications for Immune Infiltration and Immunotherapy of Hepatocellular Carcinoma

  2022cites this paper
• Subchronic exposure of individual and combined ochratoxin A and citrinin selectively affects the expression of rat renal organic cation transporters

  2022cites this paper
• Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K).

  2022cites this paper
• High Throughput Screening of a Prescription Drug Library for Inhibitors of Organic Cation Transporter 3, OCT3

  2022cites this paper
• Use of selective substrates and inhibitors to rapidly characterise batches of cryopreserved primary human hepatocytes for assessment of active uptake liability in drug discovery and development

  2022cites this paper
• Metformin and Cancer, an Ambiguanidous Relationship

  2022cites this paper
• Inflammation and intracellular exposure of dolutegravir, darunavir, tenofovir and emtricitabine in people living with HIV

  2022cites this paper
• Research Paper.

  2022cites this paper
• Regulation Mechanisms of Expression and Function of Organic Cation Transporter 1

  2021cites this paper
• Functional inhibition of Oct leads to HNF4α upregulation

  2021cites this paper
• Inhibition of the Hepatic Uptake of 99mTc-Tetrofosmin Using an Organic Cation Transporter Blocker

  2021cites this paper
• Synthesis and Bioinformatic Characterization of New Schiff Bases with Possible Applicability in Brain Disorders

  2021cites this paper
• Organic Cation Transporter I and Na+ /taurocholate Co-Transporting Polypeptide are Involved in Retrorsine- and Senecionine-Induced Hepatotoxicity in HepaRG cells.

  2021cites this paper
• Borneol enhances the protective effect against cerebral ischemia/reperfusion injury by promoting the access of astragaloside IV and the components of Panax notoginseng saponins into the brain.

  2021cites this paper
• Dual therapy with dolutegravir plus boosted protease inhibitor as a maintenance or salvage therapy in highly experienced people living with HIV.

  2021cites this paper
• Population pharmacokinetic analysis of lornoxicam in healthy Korean males considering creatinine clearance and CYP2C9 genetic polymorphism

  2021cites this paper
• Drug-Drug Interactions at Organic Cation Transporter 1

  2021cites this paper
• Inhibition of organic cation transporter 3 activity by tyrosine kinase inhibitors

  2021cites this paper
• Population pharmacokinetic analysis of lornoxicam in healthy Korean males considering creatinine clearance and CYP2C9 genetic polymorphism

  2021cites this paper
• POU2F2 promotes the proliferation and motility of lung cancer cells by activating AGO1

  2021cites this paper
• Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1–3 and Human Plasma Membrane Monoamine Transporter

  2021cites this paper
• Organic Cation Transporter 1 an Intestinal Uptake Transporter: Fact or Fiction?

  2021cites this paper
• A Single Nucleotide Polymorphism (SNP) in the SLC22A3 Transporter Gene Is Associated With the Severity of Oral Mucositis in Multiple Myeloma Patients Receiving Autologous Stem Cell Transplant Followed by Melphalan Therapy

  2021cites this paper
• Assessing Transporter‐Mediated Natural Product‐Drug Interactions Via In vitro‐In Vivo Extrapolation: Clinical Evaluation With a Probe Cocktail

  2020cites this paper
• Neurochemical characterization of mouse dorsal root ganglion neurons expressing organic cation transporter 2

  2020cites this paper
• Interactions of human organic anion transporters 1-4 and human organic cation transporters 1-3 with the stimulant drug methamphetamine and amphetamine.

  2020cites this paper
• Neuroprotective effects of metformin on traumatic brain injury in rats is associated with the AMP-activated protein kinase signaling pathway

  2020cites this paper
• CP-25 improves nephropathy in collagen-induced arthritis rats by inhibiting the renal inflammatory response.

  2020cites this paper
• Role of amino terminal substitutions in the pharmacological, rewarding and psychostimulant profiles of novel synthetic cathinones.

  2020cites this paper
• Acute infusion of angiotensin II regulates organic cation transporters function in the kidney: its impact on the renal dopaminergic system and sodium excretion

  2020cites this paper
• Strategies to reduce the risk of platinum containing antineoplastic drug-induced ototoxicity

  2020cites this paper
• Genetic factors in anthracycline-induced cardiotoxicity in patients treated for pediatric cancer

  2020cites this paper
• Comprehensive in-silico analysis of damage associated SNPs in hOCT1 affecting Imatinib response in chronic myeloid leukemia.

  2020cites this paper
• Farnesoid X Receptor Activation Stimulates Organic Cations Transport in Human Renal Proximal Tubular Cells

  2020cites this paper
• Insight into the Anticancer Activity of Copper(II) 5-Methylenetrimethylammonium-Thiosemicarbazonates and Their Interaction with Organic Cation Transporters

  2020influential citation
• Isoflavones in Soybean as a Daily Nutrient: The Mechanisms of Action and How They Alter the Pharmacokinetics of Drugs.

  2020cites this paper
• In silico modelling, identification of crucial molecular fingerprints, and prediction of new possible substrates of human organic cationic transporters 1 and 2

  2020cites this paper
• How Dysregulated Ion Channels and Transporters Take a Hand in Esophageal, Liver, and Colorectal Cancer.

  2020cites this paper
• An Interspecies Molecular and Functional Study of Organic Cation Transporters at the Blood-Brain Barrier: From Rodents to Humans

  2020cites this paper
• CMAR_A_200059 3295..3313

  2019cites this paper
• Emerging Roles of Sympathetic Nerves and Inflammation in Perivascular Adipose Tissue

  2019cites this paper
• Serotonylation: Serotonin Signaling and Epigenetics

  2019cites this paper
• Evaluation of the hepatocyte-derived cell line BFH12 as an in vitro model for bovine biotransformation

  2019cites this paper
• OTT_A_212088 6013..6022

  2019cites this paper
• ABC Family Transporters.

  2019cites this paper
• SLC Family Transporters.

  2019cites this paper
• Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.

  2019cites this paper
• Effects of SLC 22 A 2 ( rs 201919874 ) and SLC 47 A 2 ( rs 138244461 ) genetic variants on Metformin Pharmacokinetics in Pakistani T 2 DM patients

  2019cites this paper
• Personalized medicine- future of diagnosis and management of T2DM.

  2019cites this paper
• Mechanistic Links Between Obesity, Diabetes, and Blood Pressure: Role of Perivascular Adipose Tissue.

  2019cites this paper
• The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances

  2019cites this paper
• Kobe University Repository : Kernel タイトル Tit le Organic cat ion t ransporter 2 and tumor budding as independent prognost ic factors in metastat ic colorectal cancer pat ients t reated with oxaliplat in-based chemotherapy

  2019cites this paper
• Inhibition of organic cation transporter (OCT) activities by carcinogenic heterocyclic aromatic amines.

  2019cites this paper
• Role of OCT1 in hepatocellular carcinoma

  2019cites this paper
• Application of the relationship between pharmacokinetics and pharmacodynamics in drug development and therapeutic equivalence: a PEARRL review

  2019cites this paper
• Interactions of organophosphorus pesticides with solute carrier (SLC) drug transporters

  2019cites this paper
• Histamine uptake mediated by plasma membrane monoamine transporter and organic cation transporters in rat mast cell lines

  2019cites this paper
• Unraveling ‘The Cancer Genome Atlas’ information on the role of SLC transporters in anticancer drug uptake

  2019cites this paper
• Kidney Dopamine D1-like Receptors and Angiotensin 1-7 Interaction Inhibits Renal Sodium Transporters.

  2019cites this paper
• Excretory Processes in Toxicology: Drug Transporters in Drug Development

  2018cites this paper
• Carrier-mediated uptake of clonidine in cultured human lung cells

  2018cites this paper
• Interaction of rs316019 variants of SLC22A2 with metformin and other drugs- an in silico analysis

  2018cites this paper
• The farnesoid X receptor agonist obeticholic acid upregulates biliary excretion of asymmetric dimethylarginine via MATE-1 during hepatic ischemia/reperfusion injury

  2018cites this paper
• IDENTIFICATION OF ENDOGENOUS FUNCTION AND SUBSTRATE-DEPENDENT INTERACTIONS OF ORGANIC CATION TRANSPORTER 1

  2018cites this paper
• The Placental Barrier: the Gate and the Fate in Drug Distribution

  2018cites this paper
• In vitro models and systems for evaluating the dynamics of drug delivery to the healthy and diseased brain

  2018cites this paper
• PHARMACOGENETICS OF ORGANIC CATION TRANSPORTERS

  2018cites this paper
• Intestinal Absorption of Isoalantolactone and Alantolactone, Two Sesquiterpene Lactones from Radix Inulae, Using Caco-2 Cells

  2018cites this paper
• Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges

  2018cites this paper
• OCT3 promoter haplotype is associated with metformin pharmacokinetics in Koreans

  2018cites this paper
• Mitigation of cell apoptosis induced by ochratoxin A (OTA) is possibly through organic cation transport 2 (OCT2) knockout.

  2018cites this paper
• Functional organic cation transporters mediate osteogenic response to metformin in human umbilical cord mesenchymal stromal cells.

  2018cites this paper
• Genetic polymorphisms of organic cation transporter 1 (OCT1) and responses to metformin therapy in individuals with type 2 diabetes

  2018cites this paper
• Elucidation of Substrate Binding Interactions for Human Organic Cation Transporters 1 (SLC22A1) and 2 (SLC22A2) Using In Silico Homology Modeling in Conjunction with In Vitro Site-Directed Mutagenesis and Kinetic Analysis

  2018cites this paper